Dr. Sperling commented, The clinical trial to investigate the potential benefits of Conexa represents a significant commitment from Tornier to support science-based clinical research. Dr. Iannotti and I look forward to working with leading shoulder surgeons nationally and internationally on this important project.

Tears of the rotator cuff, the group of tendons and muscles that maintains the stability and range of motion of the shoulder, are among the most common of orthopaedic injuries. Large rotator cuff tears are especially challenging with research published in the Journal of Bone and Joint Surgery and other publications reporting re-tear rates that range from 29% to 94% and that increase dramatically with complicating factors such as advanced age, diabetes, and tobacco use. Patients with non-healed rotator cuff tears can face diminished function or permanent disability.

Source Tornier